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Abstract 
 
Porphyromonas gingivalis is an anaerobic Gram-negative bacteria, often associated with the pathogenesis of periodontitis. 
Periodontitis is a chronic inflammation characterized by damage to the supporting tissues of the tooth. Porphyromonas 
gingivalis locally can invade periodontal tissue and avoid host defence mechanisms. Porphyromonas gingivalis have 
virulence factors that can interfere with host immune response and cause inflammation at host tissue. The aim of this 
article is to provide an overview of the role of Porphyromonas gingivalis virulence factors such as capsules, fimbriae, 
lipopolysaccharides, and gingipain in the pathogenesis of periodontitis. The data sources were taken from PubMed and 
Google Scholar within 10 years. The role of Porphyromonas gingivalis capsule is to suppress the host's immune response 
to bacteria by reducing phagocytosis so the bacteria can survive. The roles of Porphyromonas gingivalis fimbriaeare to 
facilitate adhesion and invasion of bacteria to host cells so the damage will occur in the periodontal tissue. One of the roles 
of Porphyromoas gingivalis lipopolysaccharide is to disrupt the host immune system by disrupting the distribution of 
leukocytes around bacterial colonization so the bacteria can survive. The role of the Porphyromonas gingivalis gingipain 
is to suppress inflammatory cytokines thereby reducing the host's response by manipulating the complement system and 
disrupting the response of T cells. Porphyromonas gingivalis expresses several virulence factors involved in the 
colonization of subgingival plaque, modulates the immune response of host cells, and damages the host tissue directly so 
it can cause periodontitis.  
 
Keywords: Porphyromonas gingivalis, Virulence Factors, Immunopathogenesis, Periodontitis. 
 
Abstrak 
 
Porphyromonas gingivalis adalah bakteri Gram-negatif anaerob yang sering dihubungkan dengan patogenesis 
periodontitis. Periodontitis adalah inflamasi kronis yang ditandai dengan kerusakan pada jaringan pendukung gigi. 
Porphyromonas gingivalis secara lokal dapat menyerang jaringan periodontal dan menghindari mekanisme pertahanan 
inang. Porphyromonas gingivalis memiliki faktor virulensi yang dapat mengganggu respon imun inang dan 
menyebabkan inflamasi pada inang. Tujuan penulisan artikel ini adalah untuk memberikan gambaran peran faktor 
virulensi Porphyromonas gingivalis seperti kapsul, fimbriae, lipopolisakarida, dan gingipain dalam patogenesis 
periodontitis. Sumber data diambil dari PubMed dan Google Cendekia dalam kurun waktu 10 tahun.Peran kapsul 
Porphyromonas gingivalis sebagai salah satu faktor virulensi adalah menekan respon imun inang terhadap bakteri dengan 
mengurangi fagositosis sehingga bakteri dapat bertahan hidup. Peran fimbriae Porphyromonas gingivalis adalah untuk 
memfasilitasi adhesi dan invasi bakteri ke sel inang sehingga akan terjadi kerusakan pada jaringan periodontal. Salah satu 
peran lipopolisakarida Porphyromoas gingivalis adalah dengan mengganggu sistem imun inang dengan mengganggu 
distribusi leukosit sekitar bakteri kolonisasi, sehingga bakteri dapat bertahan hidup.  Peran gingipain Porphyromonas 
gingivalis adalah menekan sitokin inflamasi sehingga mengurangi respon inang dengan memanipulasi sistem komplemen 
dan mengganggu respon sel T. Porphyromonas gingivalis memiliki beberapa faktor virulensi yang terlibat dalam 
kolonisasi pada plak subgingiva, memodulasi respons imun sel inang, dan merusak jaringan host secara langsung 
sehingga dapat menyebabkan periodontitis. 
 
Kata kunci: Porphyromonas gingivalis, Faktor Virulensi, Imunopatogenesis, Periodontitis. 
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INTRODUCTION 
 
Periodontitis is a chronic inflammatory disease cha-
racterized by damages to the supporting tissues of the 
teeth, including the gingiva, periodontal ligament, and 
alveolar bone. When inflammation becomes chronic, 
the adaptive immune response will be active by invol-
ving cellular and non-cellular mechanisms of acquired 
immunity. So periodontitis can be regarded as an im-
mune-inflammatory disease.
1-4
The prevalence of peri-
odontal disease globally is between 20-50%.
5, 6
 
Some oral bacteria have a role in the pathogennesis 
of periodontitis for example, Porphyromonas gingi-
valis, Treponema denticola, and Tannerella forsythia, 
so they are referred as periodontopathic bacteria.
7-9
 
Among these three bacteria, P. gingivalis is the most 
common bacterium associated with periodontitis.
10
 
The pathogenesis of periodontitis begins with the 
formation of subgingival bacterial biofilms. Bacterial 
biofilms in subgingival potentially disrupt the host im-
mune. Host response to bacteria is the main mecha-
nism in periodontitis.
1112
 
The existence of P. gingivalis in periodontal pockets 
was reported to influence the development of perio-
dontitis and the finding of P. gingivalis was positively 
correlated with pocket depth.
13
 Several experimental in 
animal models were reported that P. gingivalis to be 
able to induce inflammatory responses and cause bone 
loss alveolar.
7
  Potential virulence factors of P. gingi-
valis are capsules, fimbriae, lipopolysaccharide, and 
cysteine proteinases or gingipain.
1314
 The dominant P. 
gingivalis virulence factor found as a cause of perio-
dontitis can be used as a vaccine subunit to prevent pe-
riodontitis. This paper provides a better understanding 
of the characteristics of P. gingivalis virulence factors 
and cellular or molecular interactions between P. gin-
givalis and the host, so that prevention and therapy in 
controlling the development of periodontitis can be ad-
dressed appropriately. The aim of this article is to pro-
vide an overview of the role of P. gingivalis virulence 
factors such as capsules, fimbriae, lipopolysaccharides, 
and gingipain in the pathogenesis of periodontitis to 
improving understanding which is the significance of 
the study. 
Periodontal disease is a pathological state of perio-
dontium structure.
9
Gingivitis is inflammation of the 
gingival tissue that is characterized by redness, swell-
ling, and bleeding tissue, caused by dental plaque.  
Alveolar bone and periodontal ligament are not in-
volved in gingivitis, so there is no influence on the at-
tachment of the teeth.
9
 Periodontitis refers to inflam-
mation plaque-induced periodontal tissue that leads to 
damage to the periodontal ligament and alveolar bone. 
Periodontitis causes the formation of the periodontal 
pocket, the main clinical sign of periodontitis. The 
pe-riodontal pocket is a place for bacterial 
coloniza-tion.
9
 Another characteristic feature of 
periodon-titis is the damage of alveolar bone due 
to the activation of osteoclastogenesis. This is 
irrever-sible and causes loss of tooth support.
15
 
Periodontitis is caused by interactions between 
species of bacteria that can cause this disease. Por-
phyromonas gingivalis, Actinobacillus actinomy-
cetemcomitans, Treponema denticola, Tannerella 
forsythia, Prevotella intermedia, Fusobacterium 
nucleatum, and Campylobacter spp. found in this 
disease and affected the development of the di-
sease. 
1617
 From subgingival plaque periodontitis 
patients, P. gingivalis was found 85.75%.
918
P. 
gingivalis exposure to subgingival non-human pri-
mates and mice caused bone loss.
7
 
P. gingivalis is non-acetyl, non-motile, and black 
pigmented Gram-negative bacteria, need anaero-
bic conditions to grow and need the availability of 
heme and vitamin K in its environment. P. gingi-
valis is also an asaccharolytic bacteria, which uses 
amino acids as an energy source, it is useful for li-
ving in deep periodontal pockets, where there is a 
little sugar for energy sources. On subgingival bio-
film, P. gingivalis is a secondary colony so that it 
is found near and interacts with gingival tissue. 
This is due to P. gingivalis is an anaerobic obli-
gate bacteria.
19,20
P.gingivalis forms a black pig-
mented colony on the blood agar plate, this is re-
lated to heme aggregation on the cell surface be-
cause these bacteria need iron as a nutrient.
13
 
Bacteria must attach on teeth or mucosal surface 
to survive in the oral cavity.
21
 Adhesion proper-
ties are very important to provide resistance from 
the salivary flow. The interaction between ad-
hesin on the bacterial surface and receptors on the 
oral surface causes adhesion. Bacterial adhesin is a 
component of cell structure, such as capsules.
9
 
The study said that increased resistance to pha-
gocytosis was correlated with increased capsu-
lation.
10
 Other research reveals that P. gingivalis 
strains W50 and W83 which have thicker cap-
sules, decreased leukocyte production than strain 
376. This suggests that the differences in bacteria 
strains may be caused by differences in capsular 
structure.
9
 Recent findings suggest that P. gingi-
valis capsules can induced host responses with re-
duced cytokines IL-1, IL-6, and IL-8 by fibro-
blasts.
22
 Regulation of adaptive immune responses 
has been shown to decrease against encapsulated 
P. gingivalis. IgA response was signifycantly in-
8   dentika Dental Journal, Vol 23, No. 1, 2020: 6-12 
 
 
creased in animals exposed to non-encapsulated 381 
strains. These results showed that bacteria capsule can 
avoid adaptive and humoral immunity responses.
10
 
Bacterial capsules affect the maturation of dendritic 
cells because capsules protect the structure of the ou-
termost bacteria that interacts with dendritic cells. Re-
search shows that the non-encapsulated P.gingivalis 
PgC strain can induce dendritic cell maturation faster 
than the encapsulated W50 strain. These studies 
showed that P. gingivalis capsules inhibit host res-
ponse, it can cause bacteria to escape the host immune 
defence so they can survive and grow.
10
 
P. gingivalis fimbriae is a thin, stringy cell surface 
protrusion that facilitates adhesion to host cells and 
other bacteria. With fimbriae, P. gingivalis can adhe-
sion to early bacterial colonies and plays a role in the 
development of biofilms. Types of fimbriae are I (ma-
jor) type fimbriae called fimbrillin or FimA coded by 
the fimA gene have an important role in colonization 
and invasion, II (minor) type fimbriae called Mfa sub-
unit protein coded by the mfa1 gene.
23, 24
 The special 
role of fimbriae is to induce bone destruction in the ex-
perimental periodontitis model.
9
 
P. gingivalis FimA and Mfa1 are strong inducers of 
pro-inflammatory molecules. P. gingivalis FimA is re-
ported to induce inflammatory molecules such as 
TNFα MCP-1, IL-6, IL-8, IL-1β. P. gingivalis Mfa1 is 
reported to induce inflammatory molecules, such as 
IL-6, IL-1β, and TNFα.7 
When fimbria interacts with TLR2/ CD14, the pro-
adhesive pathway is initiated. This causes the induc-
tion of Rac1/PI3K, which activates CR3 so that af-
finity is increased.
25-27
 Activation of the TLR2 sig-
nalling pathway in and out by fimbriae leads to in-
creased adhesion of monocytes that depend on CR3 
and transendothelial migration. P. gingivalis will bind 
to CR3, enter the cell, and inhibit IL-12p70, which 
consists of subunits p35 and p40. When P. gingivalis 
fimbriae interact with CR3, which leads to outside-in 
signaling, it affects ERK1/2, thereby reducing the re-
gulation of IL-12 p35 and IL-12 p40, this causes in-
hibition of IL-12p70 production. In addition, the 
stimulation of TLR2 by P. gingivalis will induce NF-
kB activation (Figure 1).
28, 29
 Thus, CR3, which is 
exploited by P. gingivalis can interfere with the pha-
gocytic process of bacteria mediated by IL-12, thereby 
increasing its viability and capacity to cause perio-
dontitis. IL-12p70 acts to activate T and NK cells that 
produce IFN-γ, which functions to activate the bacte-
ricidal function in macrophages.
30 
 
 
 
Figure 1. Interaction P. gingivalis with TLR2 and CR2 
to undermine innate immunity29 
 
Lipopolysaccharides (LPS) are relatively large 
molecules with a size of at least 10 kDa. Bacterial 
lipopolysaccharides consist of distal polysaccha-
rides (O-antigens), core oligosaccharides and hy-
drophobic domains known as lipid A or endo-
toxins as contained.
31
 Lipid A is the lipopolysac-
charides biological active region, caused deregu-
lation innate immune that interacts with toll-like 
receptors (TLR) 2 and 4.
9
 
Bacteria lipopolysaccharides have function to 
maintain the integrity and structure of cells, con-
trolling the entry of toxic chemicals and hydro-
phobic molecules. Many studies have reported the 
ability of lipopolysaccharides P. gingivalis to in-
duce inflammation and disrupt the host bone re-
modelling process.
9
 
The role of P. gingivalis lipopolysaccharides is 
to interfere with the innate host through leuko-
cytes distribution around bacterial colonization. 
Also, lipopolysaccharides reduce gingival epithet-
lial cell’s ability to secrete IL-8, so the activation 
of basophils, eosinophils, and neutrophils are af-
fected. Without an effective innate immune de-
fence, the number of periodontal bacteria can in-
crease rapidly. The presence of bacterial colonies 
in periodontal tissue and the failure of the host de-
fence system is an etiology observed from perio-
dontal disease. In addition to inducing the syn-
thesis of proinflammatory cytokines, P. gingivalis 
lipopolysaccharides inhibit osteoblastic differen-
tiation and mineralization in periodontal ligament 
stem cells that have a role in tissue regeneration.
9
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Gingival fibroblasts are reported to induce pro-in-
flammatory cytokines, such as TNFα, IL-8, IL-1, and 
IL-6 after exposed by P. gingivalis lipopolysaccha-
rides. The interaction of P. gingivalis lipopolysac-
charide and TLR on fibroblasts activates these cells to 
induce proinflammatory cytokines. It was also repor-
ted that P. gingivalis lipopolysaccharide induces the 
secretion of IL-8 and IL-1β from human monocyte 
cells. Immunological dysregulation is caused by hete-
rogeneity in the structure of lipopolysaccharides thus 
inducing an opposite immune response.
7, 32
 
Gingipain is a cysteine proteinase secreted by P. gin-
givalis and also accounts for 85% of the total pro-
teolytic activity of P. gingivalis. Based on the spe-
cificity of the substrate, it is divided into specific ar-
ginine gingipain (Arg-X) and lysine (Lys-X). Argi-
nine Gingipain can decrease extracellular matrix com-
ponents, including complement factors, cytokines, 
immunoglobulins, and integrin-fibronectin binding. 
There are two types of arginine gingipain, RgpA, con-
tains adhesion and proteolytic domains, and RgpB 
only contains proteolytic domains. There is one type of 
lysine gingipain, Kgp, which contains adhesion and 
proteolytic. Between the Kgp and Rgpa, adhesion do-
mains have a similar sequence.
13, 33
 
In human T cells, including CD4, CD8, and CD2, 
gingipain can cleave some co-stimulatory molecules, 
which can influence host cell-mediated immune res-
ponses to periodontopathic biofilms. An imbalance of 
Th1 polarization with CD4 T cells is associated with 
the development of periodontitis. Interferon-c levels 
and IL-12 were significantly increased in gingival 
tissue biopsy and gingival crevicular fluid from pa-
tients with periodontitis. Interferon-c and IL-12 play in 
regulating tissue damage and bone resorption in 
periodontitis. These data indicate that pro-inflam-
matory and anti-inflammatory Thcytokines are de-
graded and deactivated by gingipain, so it can cause 
host immune dysregulation.
7
 
Gingipain (HRgpA RgpB, Kgp) inhibits the alter-
native, classical, and lectin pathways that activate the 
complement by degrading the central complement 
component of C3. Inhibition of these pathways causes 
the complement activation C3b opsonization memb-
rane attack complex (MAC) to be inhibited. HrgpA P. 
gingivalis protecting from the complement system by 
binding to C4BP, the C4b binding protein for inhi-
biting complement activation C3b opsonization MAC 
(Figure 2).
34, 35 
 
 
 
 
Figure 2. Role of gingipain in the manipulation of 
complement system35 
 
P. gingivalis also interacts with TLR2 with 
CD14 and TLR1. Part of the TLR2 response is 
subverted by P. gingivalis through cross-talk sig-
nalling with complement receptors. HRgpA and 
RgpB P. gingivalis release active C5a from C5, 
then actives the C5a receptor (C5aR) in mac-
rophages, then induce intracellular Ca
2+
 signalling, 
thereby increasing cAMP, which is also induced 
by TLR2 activation. The cAMP will activate pro-
tein kinase A (PKA), so it will deactivate glycol-
gen synthase kinase-3β (GSK3β) and inhibit intra-
cellular defenses that depend on iNOS in macro-
phages so that bacterial killing does not occur 
(Figure 2).
35, 36
 
 
DISCUSSION  
 
In the course of evolution, P. gingivalis has 
learned to disrupt the innate defence system, for 
example, it will interfere with the complement 
system and TLRs, thus disturbing the signalling 
pathway. The effects of interference with the re-
gulation of the host system will affect periodontal 
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disease, whether it will develop or not. In the initial 
stages, decreasing the inflammatory response and 
avoidance of the host system will help P. gingivalis in 
colonizing, attacking and defending in the targeted lo-
cation. At a later stage, P. gingivalis can induce in-
flammation to facilitate the nutritional needs required 
by P. gingivalis. 
P. gingivalis tactics to damage innate immunity so 
can increase the survival of bacteria in the periodontal 
biofilm community. For example, the manipulation of 
complement by P. gingivalis is a strategy to provide 
means for other species to survive on biofilms, then to 
continue the opportunity to colonize and in return, the 
availability of nutrients for P. gingivalis. This capacity 
occurred as P. gingivalis bearing the virulence factors 
such as fimbriae, capsules, lipopolysaccharide, and 
gingipain. Studies show that although P. gingivalis 
exists in low quantities, this species qualitatively af-
fects oral microbiota, which in turn has a role in bone 
loss induced by P. gingivalis. For this reason, P. gin-
givalis is a 'keystone' bacteria in subgingival biofilms. 
The role of capsules as one of the P. gingivalis viru-
lence factors is by suppressing the host immune res-
ponse to bacteria, so phagocytosis is reduced, and the 
bacteria are survived. Capsules are one of the impor-
tant P. gingivalis virulence factors because have se-
veral virulence properties, which can serve as a target 
for the development of therapeutic strategies. Research 
shows immunization of P. gingivalis capsules in mice 
stimulates the IgG response that reacts with all P. gin-
givalis bacteria. Furthermore, vaccination with P. gin-
givalis capsules prevents bone loss caused by P.gin-
givalis exposure in the murine model.
10
 Further re-
search will determine the efficacy of P. gingivalis cap-
sules as vaccine candidates for use in the prevention of 
periodontitis.  
It is known that P. gingivalis fimbriae are highly im-
munogenic and immunization with purified fimbria 
from P. gingivalis 381 inhibits the progression of pe-
riodontal disease.
37
 Fimbriae are responsible for the 
adhesion and invasion of bacteria that can cause perio-
dontal tissue damage. Some researchers have made it a 
vaccine candidate, because of its ability to facilitate ad-
hesion and invasion of bacteria into tissues. Immuni-
zation of mice with P. gingivalis FimA which pro-
duces anti-FimA monoclonal antibodies through 
passive immunization has an activity to inhibit the 
binding of P. gingivalis to the tooth surface. Fur-
ther research must be carried out to characterize 
the inhibitory properties of bacteria mediated by 
monoclonal antibodies.
38
 
Lipopolysaccharide P. gingivalis gives rise to a 
weak immune response. Besides, P. gingivalis can 
synthesize heterogeneous populations of lipid A 
molecules, which differ slightly from each other in 
their structure. The lipid structure of P. gingivalis 
has a role in interfering with the oral immune ho-
meostasis needed to maintain oral health, thereby 
increasing periodontal disease. The structure of li-
pid A activates immune cells selectively to in-
duce immune responses without triggering the 
production of toxic mediator levels, making lipid 
A a good vaccine candidate.
39
 
Gingipain is a very virulent cysteine proteinase 
secreted by P. gingivalis which causes the deve-
lopment of periodontitis. Gingipain decreases in-
flammatory cytokines thereby reducing host res-
ponse by manipulating complement and disrupt-
ting T cell responses. Gingipain is also involved in 
vascular permeability. Gingipain can be a vaccine 
candidate to prevent periodontitis, because of its 
strong virulent nature. In one study, mice immu-
nized with the RgpA DNAvaccine observed 
changes in cytokine levelsInterleukin (IL) -2, 4, 5 
and 12 productions are found to be increased. 
Other studies have shown that the RgpA vaccine 
can induce high serum antibody levels against P. 
gingivalis. So it can be concluded that the RgpA 
DNA vaccine can induce cellular and humoral im-
mune responses to protect P. gingivalis. Further 
research evaluates the protective effect of the 
HRgpA DNA vaccine against gingipain virulence 
in bone loss. The result is a significant increase in 
specific IgG against P. gingivalis.
40
 
P. gingivalis expresses several virulence factors 
involved in the colonization of subgingival plaque, 
modulates the immune response of host cells, and 
damages the host tissue directly so that it can 
cause periodontitis.  
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